AAAAI 2021: Asthma Not an Independent Predictor of Severe COVID-19 Outcomes
March 05, 2021

Recent research presented at AAAAI 2021 Virtual Annual Meeting suggests asthma is not an independent risk factor for severe COVID-19 or hospitalization.

Significant Reductions in Exacerbations Seen in Broad Population of Severe Asthma Patients
March 01, 2021

Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.

Expert-guided Online Decision Tool Supports Real-time Treatment Choice for Severe Asthma
March 01, 2021

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.